{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:49:34Z","timestamp":1790776174127,"version":"4.1.0"},"reference-count":67,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR000136"],"award-info":[{"award-number":["KL2 TR000136"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Adv Cell Gene Ther"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1002\/acg2.48","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:36:37Z","timestamp":1547638597000},"page":"e48","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics"],"prefix":"10.1155","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-9887","authenticated-orcid":false,"given":"Abhishek A.","family":"Mangaonkar","sequence":"first","affiliation":[{"name":"Division of HematologyDepartment of MedicineMayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Division of HematologyDepartment of MedicineMayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"SHCE Swerdlow NL Harris ES Jaffe WHO classification of tumours of haematopoietic and lymphoid tissues 2018 International Agency for Research on Cancer Lyon France 82 86"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24939"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25104"},{"issue":"3","key":"e_1_2_8_6_1","first-page":"191","article-title":"Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia","volume":"19","author":"Such E","year":"2013","journal-title":"Transfuze a Hematologie Dnes"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2243-z"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134858"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23962"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030957"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23373"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.04.018"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.125"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1169411"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12213"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10767"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.113"},{"issue":"23","key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.V126.23.1673.1673","article-title":"Prognostic impact of ASXL1 mutations in MDS and CMML","volume":"126","author":"Sallman D","year":"2015","journal-title":"Blood"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-210039"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311019"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-460170"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0203-0"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23751"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23846"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3420"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09999"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.012"},{"issue":"11","key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/bloodadvances.2018017400","article-title":"Oncogenic N\u2010Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells","volume":"2","author":"Jin X","year":"2018","journal-title":"Blood Adv"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1034406"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1243681"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.355"},{"issue":"21","key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood.V116.21.3997.3997","article-title":"Myeloid\u2010derived suppressive cells belonging to the leukemic clone account for immunosuppression in CMML","volume":"116","author":"Droin N","year":"2010","journal-title":"Blood"},{"issue":"1","key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2009-05-224352","article-title":"Alpha\u2010defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia","volume":"115","author":"Droin N","year":"2010","journal-title":"Blood"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21848"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800707"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-557587"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.01.002"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779579"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-620781"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.66"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309145"},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"208.5","DOI":"10.4049\/jimmunol.198.Supp.208.5","article-title":"Diversity of human monocyte subsets revealed by CyTOF mass cytometry","volume":"198","author":"Hamers AA","year":"2017","journal-title":"J Immunol"},{"issue":"15","key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/bloodadvances.2018019224","article-title":"Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories","volume":"2","author":"Loghavi S","year":"2018","journal-title":"Blood Adv"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2112"},{"issue":"6","key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg P","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-452938"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.88"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.3314"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-714030"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.117"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21792"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2781"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-607341"},{"issue":"1","key":"e_1_2_8_56_1","first-page":"162","article-title":"Promising results of a phase 1\/2 clinical trial of ruxolitinib in patients with chronic myelomonocytic leukemia","volume":"130","author":"Padron E","year":"2017","journal-title":"Blood"},{"key":"e_1_2_8_57_1","article-title":"Results from ongoing phase 1\/2 trial of SL\u2010401 in patients with relapse\/refractory CMML","author":"Patnaik MAH","year":"2018","journal-title":"Eur Hematol Assoc"},{"key":"e_1_2_8_58_1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/ajh.25246","article-title":"Splenectomy in patients with chronic myelomonocytic leukemia: indications, histopathological findings and clinical outcomes in a single institutional series of 39 patients","volume":"93","author":"Pophali P","year":"2018","journal-title":"Am J Hematol"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.09.018"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705369"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.375"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.210"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03552.x"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.366"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12073"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.01.078"},{"issue":"11","key":"e_1_2_8_67_1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1804714","article-title":"Mutation clearance after transplantation for myelodysplastic syndrome","volume":"379","author":"Duncavage EJ","year":"2018","journal-title":"N Engl J Med"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-724500"}],"container-title":["ADVANCES IN CELL AND GENE THERAPY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facg2.48","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acg2.48","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acg2.48","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acg2.48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:31:32Z","timestamp":1694561492000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acg2.48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,4,19]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1002\/acg2.48"],"URL":"https:\/\/doi.org\/10.1002\/acg2.48","archive":["Portico"],"relation":{},"ISSN":["2573-8461","2573-8461"],"issn-type":[{"value":"2573-8461","type":"print"},{"value":"2573-8461","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}